Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis

Gandhi, ShivZelman, SaraDe Armas, Ricardo EduardoHemond, Christopher CLevy, Alexander NSingh, SiddharthKorzenik, JoshuaJangi, Sushrut2023-05-202023-05-202022-03-26Gandhi S, Zelman S, De Armas RE, Hemond C, Levy AN, Singh S, Korzenik J, Jangi S. Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis. Inflamm Bowel Dis. 2022 Oct 3;28(10):1614-1617. doi: 10.1093/ibd/izac053. PMID: 35348692; PMCID: PMC9527605.1536-484410.1093/ibd/izac05335348692https://hdl.handle.net/20.500.14038/52080Lay Summary Patients with MS and IBD were as likely to have stricturing, fistulizing, and extensive IBD as IBD controls. Although MS-IBD patients were less likely to initiate anti-TNF therapy, they did not have worsened risk of progression to surgery on follow-up.enAnti-TNF therapyAutoimmune diseaseDemyelinationUMCCTS fundingNatural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple SclerosisJournal ArticleInflammatory bowel diseases